Lombard Medical Inc (EVAR)

0.05
0.00 (0.00)
OTC : Health Care
Prev Close 0.05
Open 0.05
Day Low/High 0.05 / 0.05
52 Wk Low/High 0.02 / 0.75
Volume 1.43K
Avg Volume 79.70K
Exchange OTC
Shares Outstanding 27.95M
Market Cap 6.15M
EPS -1.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Lombard Medical Announces First Aorfix(TM) Cases In New Zealand Following Expansion In Asia-Pacific Region

Lombard Medical Announces First Aorfix(TM) Cases In New Zealand Following Expansion In Asia-Pacific Region

--Cases Led by Prof. Andrew Holden, Globally-Recognized Expert on Endovascular Treatments--

Lombard Medical's Aorfix(TM) Endovascular Stent Graft Adopted By Surgeons At Veteran Affairs Medical Centers

Lombard Medical's Aorfix(TM) Endovascular Stent Graft Adopted By Surgeons At Veteran Affairs Medical Centers

Highlights Value of Uniquely Broad Label for Treating Patients With Abdominal Aortic Aneurysms, Including Those With Complex Anatomies

First Post Approval Cases With Aorfix(TM) Performed In Japan

First Post Approval Cases With Aorfix(TM) Performed In Japan

Lombard Medical Launches Device in Second Largest Standalone Endovascular Aneurysm Repair Market Through Exclusive Distribution Partner Medico's Hirata

Lombard Medical Reports Second Quarter 2014 Financial Results

Lombard Medical Reports Second Quarter 2014 Financial Results

Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAA), today reported operational progress and financial results for the ...

Lombard Medical’s Aorfix™ Receives Regulatory Approval In Japan For Treatment Of Abdominal Aortic Aneurysms

Lombard Medical’s Aorfix™ Receives Regulatory Approval In Japan For Treatment Of Abdominal Aortic Aneurysms

Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAA), today announced that its lead product, Aorfix™, an endovascular ...

Lombard Medical Announces 2014 Second Quarter And Six-Month Financial Results Conference Call And Release Date

Lombard Medical Announces 2014 Second Quarter And Six-Month Financial Results Conference Call And Release Date

Lombard Medical, Inc (Nasdaq: EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAA), today announced that it will release its 2014 second quarter and six-month...